The treatment landscape for angina pectoris continues to evolve as cardiovascular diseases remain one of the leading causes of mortality worldwide. Rising cases of coronary artery disease, sedentary lifestyles, diabetes, obesity, and hypertension are significantly increasing the demand for effective therapeutic solutions. Pharmaceutical companies are actively investing in innovative therapies...
Tiếng Việt 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)